Technologies

time icon Aug. 5, 2016

Enzyme/Redox Polymer Supercapacitor Device

Technology description

Invention Summary

U-6166 is a hybrid enzyme redox polymer supercapacitor bio-battery capable of generating a capacitance on the order of 300±100 F/g when multi-walled carbon nanotubes are used in conjunction with redox polymers. When multi-walled carbon nanotubes only are used, a capacitance on the order of 102 F/g is obtained; therefore, the inclusion of redox polymers leads to a two to three fold increase in capacitance. Conduction polymers are usually used in supercapacitors to fill in the void space between the multi-walled carbon nanotubes but the conduction polymer does not allow for ion transfer. This results in a smaller capacitance increase than observed when only multi-walled carbon nanotubes are used. Redox polymers allow ion transfer making them an ideal replacement for conduction polymers. This technology would have the potential to be used in multiple different markets including implantable medical devices, phones and any application that uses a supercapacitor. Currently, the main issue with supercapacitors is the fact that they do not have the energy storage capacity that rivals lithium ion batteries.

Market Opportunity

A typical customer for U-6166 would be medical device manufactures of pacemakers, ICDs, and spinal cord stimulators. The total number of implantable devices that sold reached 715,000 units in 2014 and it is expected that 816,000 units will be sold in 2020, with a CAGR of 1.9%. Overall, the number of units sold of pacemakers and ICDs remained constant over this time, but the number of spinal cord stimulators sold increased with a CAGR of 7.9%. Each of these implantable devices that are sold contains a lithium ion battery. U-6166 is a completely new technology that is meant to replace the lithium ion batteries contained within an implantable medical device. Supercapacitors that can deliver the required voltages cost $150 on the low end4. Assuming that U-6166 would be able to sell for $150 and a 10% adoption rate, 81,600 devices would be sold with revenue of $12.2 million.

Advantages

  • Increased capacitance when compared to equivalent supercapacitors
  • Operate at near neutral pH and ambient temperature
  • Charges like a capacitor but discharges over a longer period of time like a battery

由于技术保密工作限制,技术信息无法完全展现,请通过邮箱或短信联系我们,获取更多技术资料。

More information

Categories
  • Cardiology
  • Medical instruments
Keywords:

multi-walled carbon nanotubes

energy storage capacity

medical device manufactures

spinal cord stimulators

10% adoption rate

下载 PDF 文档


感兴趣

Contact us

知繁业茂-yintrust logo知繁业茂-Branchly Innovation logo 知繁业茂-autmasia logo迈科技 logo